These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 1245331)
1. Reporting adverse drug reaction in a small hospital. Magee PE; Garrison TJ Hospitals; 1976 Jan; 50(2):63-4, 66-7. PubMed ID: 1245331 [No Abstract] [Full Text] [Related]
2. Assessment of adverse drug reactions in the hospital setting: considerations. Jones JK Hosp Formul; 1979 Aug; 14(8):769-72, 774, 776. PubMed ID: 10243167 [No Abstract] [Full Text] [Related]
3. Developing an adverse drug reaction reporting program. Nelson RW; Shane R Am J Hosp Pharm; 1983 Mar; 40(3):445-6. PubMed ID: 6846354 [No Abstract] [Full Text] [Related]
4. Hospital pharmacy program for reporting adverse drug reactions. Jacinto MS; Kleinmann K Am J Hosp Pharm; 1983 Mar; 40(3):444-5. PubMed ID: 6846353 [No Abstract] [Full Text] [Related]
5. Adverse drug reaction reporting--a practical program. Canada AT Am J Hosp Pharm; 1969 Jan; 26(1):18-23. PubMed ID: 5763884 [No Abstract] [Full Text] [Related]
6. Comparison of pharmacy-based concurrent surveillance and medical record retrospective reporting of adverse drug reactions. Schumock GT; Thornton JP; Witte KW Am J Hosp Pharm; 1991 Sep; 48(9):1974-6. PubMed ID: 1928145 [No Abstract] [Full Text] [Related]
7. Food and Drug Administration's adverse drug reaction monitoring program. Lee B; Turner WM Am J Hosp Pharm; 1978 Aug; 35(8):929-32. PubMed ID: 677138 [TBL] [Abstract][Full Text] [Related]
10. A cost/impact analysis of selected clinical pharmacy functions in three hospitals. Munzenberger PJ; Swanson LN; Smith RE; Zalewski FH; Schwartz JI; Billingsley LA Am J Hosp Pharm; 1974 Oct; 31(10):947-53. PubMed ID: 4440692 [No Abstract] [Full Text] [Related]
11. Postmarketing surveillance. Oleen MA Can J Hosp Pharm; 1987 Oct; 40(5):171-2, 179-80. PubMed ID: 10284449 [TBL] [Abstract][Full Text] [Related]
12. A survey of adverse drug reaction reporting programs in select hospitals. Case RL; Guzzetti PJ Hosp Pharm; 1986 May; 21(5):423-6, 431-4, 438. PubMed ID: 10276799 [TBL] [Abstract][Full Text] [Related]
13. Improving adverse drug reaction reporting in the community setting. McCloskey BA Med Interface; 1996 May; 9(5):85-7. PubMed ID: 10157690 [TBL] [Abstract][Full Text] [Related]
14. Adverse drug reaction reporting--proposal to implement a revised system. Linkewich JA Hosp Pharm; 1989 Feb; 24(2):122-4. PubMed ID: 10292192 [No Abstract] [Full Text] [Related]
15. The hospital pharmacist in adverse drug reaction reporting programs. Cleveland CB Am J Hosp Pharm; 1967 May; 24(5):276-8. PubMed ID: 6041782 [No Abstract] [Full Text] [Related]
16. National adverse drug reaction surveillance. 1986. Faich GA; Dreis M; Tomita D Arch Intern Med; 1988 Apr; 148(4):785-7. PubMed ID: 3355297 [TBL] [Abstract][Full Text] [Related]
17. Hospital organizational performance and size. Starkweather DB Inquiry; 1973 Sep; 10(3):10-8. PubMed ID: 4269725 [No Abstract] [Full Text] [Related]
18. Adverse drug reaction reporting in Canadian hospitals. Naylor MJ Can J Hosp Pharm; 1978; 31(5):184. PubMed ID: 10239058 [No Abstract] [Full Text] [Related]
19. Reporting adverse drug therapy results. Pa Med; 1990 Jun; 93(6):29. PubMed ID: 2367135 [No Abstract] [Full Text] [Related]
20. A perspective on drug reaction reporting. Schneller GH Am J Pharm Sci Support Public Health; 1974; 146(3):70-4. PubMed ID: 4850260 [No Abstract] [Full Text] [Related] [Next] [New Search]